01 1Navinta
01 1TRIHEPTANOIN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-04-16
Pay. Date : 2024-03-22
DMF Number : 39441
Submission : 2024-03-26
Status : Active
Type : II
20
Navinta Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TRIHEPTANOIN, with a corresponding US DMF Number 39441.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 16, 2024, and payment made on March 22, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
